Screener
aTyr Pharma ATYR EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from aTyr Pharma’s reported figures.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's EBIT?
- aTyr Pharma (ATYR) reported EBIT of -$10.88M in Q2 2026.
- How has aTyr Pharma's EBIT changed year-over-year?
- aTyr Pharma's EBIT increased by 46.4% year-over-year, from -$20.31M to -$10.88M.
- What is the long-term trend for aTyr Pharma's EBIT?
- Over 4 years (2021 to 2025), aTyr Pharma's EBIT has grown at a 22.9% compound annual growth rate (CAGR), from -$34.02M to -$77.63M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about aTyr Pharma's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude